Applications from the field of Forensics focused on SFC from Agilent Technologies | LabRulez LCMS

Quantitative Determination of Drugs Using Supercritical Fluid Chromatography with Triple Quadrupole Mass Spectrometry

Applications

| 2020 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ, SFC

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ, SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Applications

| 2017 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ, SFC

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ, SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Analysis of Polar and Ionic Drugs in Doping Control by Ion‑Exchange Chromatography with the Agilent 1260 Infinity II SFC System

Applications

| 2020 | Agilent Technologies

SFC

Instrumentation

SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Analysis of Polar and Ionic Drugs in Doping Control by Ion‑Exchange Chromatography with the Agilent 1260 Infinity II SFC System

Applications

| 2020 | Agilent Technologies

SFC

Instrumentation

SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Development of a Method for the Chiral Separation of D/L‑Amphetamine

Applications

| 2017 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ, SFC

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ, SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Applications

| 2017 | Agilent Technologies

LC/MS, LC/MS/MS, LC/QQQ, SFC

Instrumentation

LC/MS, LC/MS/MS, LC/QQQ, SFC

Manufacturer

Agilent Technologies

Industries

Forensics

Applications from the field of Forensics focused on SFC from Agilent Technologies | LabRulez LCMS

Quantitative Determination of Drugs Using Supercritical Fluid Chromatography with Triple Quadrupole Mass Spectrometry

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Analysis of Polar and Ionic Drugs in Doping Control by Ion‑Exchange Chromatography with the Agilent 1260 Infinity II SFC System

Analysis of Polar and Ionic Drugs in Doping Control by Ion‑Exchange Chromatography with the Agilent 1260 Infinity II SFC System

Development of a Method for the Chiral Separation of D/L‑Amphetamine

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Related content

Washington University collaborates with Agilent, Merck to expand metabolomics research

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

An innovative approach to planar chiral substances